All
Vitamin E insignificant in yellow nail
April 1st 2004Washington - In the first study of its kind, three siblings with congenital yellow nail syndrome were treated with topical vitamin E for 12 months. Upon completion of the placebo-controlled study, researchers at Yale University found that vitamin E was not statistically significant compared to placebo in meeting two clinical endpoints: nail growth and appearance.
Gentle, effective therapy for mild acne vulgaris
April 1st 2004Washington, D.C. - For patients with mild acne vulgaris and few inflammatory lesions, an over-the-counter 2 percent salicylic acid plus naturals complex is a viable and effective treatment to use over a short period of time, according to Richard S. Berger, M.D.
Phase II study shows oral tazarotene treatment yields QOL benefits for sufferers of severe acne
April 1st 2004Washington D.C. ?? Patients with severe nodulocystic acne treated with oral tazarotene experience a substantial improvement in acne-specific health-related quality of life (HRQOL), according to the results of a Phase II dose-ranging study presented by Patricia S. Walker, M.D., Ph.D., at the annual meeting of the American Academy of Dermatology.
Contact dermatitis from topicals tops list of adverse drug reactions
April 1st 2004Boca Raton, Fla. - Contact dermatitis from topical medications is the most common type of adverse drug reaction, and allergic contact dermatitis is the most common and most important form of contact dermatitis induced by topical drugs, according to James S. Taylor, M.D., head of the industrial dermatology section of the department of dermatology at the Cleveland Clinic Foundation in Cleveland. "Patients with medicament contact dermatitis usually have a good prognosis, but with a propensity for relapse," Dr. Taylor said.
Ancient 'cure' finds believers in the 'burbs
April 1st 2004Maui, Hawaii - For thousands of years, people have flocked to the Dead Sea searching for relief for their itchy skin. Now, Chicago-area psoriasis and atopic dermatitis sufferers are bathing in reconstituted Dead Sea water at a suburban clinic.
Azelaic acid gel is well-tolerated
March 1st 2004Washington - Sensitive skin is much more common among persons with rosacea compared to the general population, but even those rosacea patients with confirmed heightened skin sensitivity are likely to tolerate application of azelaic acid 15 percent gel (Finacea), according to the results of a prospective study undertaken by Zoe D. Draelos, M.D.
Computer Monitor: Technology for trekkers
March 1st 2004I spend about two months a year away from my office attending meetings and vacationing. Often I am many time zones away, where I want to avoid the cost and inconvenience of phoning home to the office every day. Some of my staff are not regular users of e-mail, and it is not practical to train them for occasional use of my office email system.
Azelaic acid gel is well-tolerated
March 1st 2004Washington - Sensitive skin is much more common among persons with rosacea compared to the general population, but even those rosacea patients with confirmed heightened skin sensitivity are likely to tolerate application of azelaic acid 15 percent gel (Finacea), according to the results of a prospective study undertaken by Zoe D. Draelos, M.D.
Maggot debridement therapy promising
March 1st 2004Akron, Ohio - Maggot debridement therapy (MDT), a controversial, but reportedly effective wound-healing technique, has attracted a following abroad in recent years, and is now gaining interest in the United States, as well. MDT is the medical use of live maggots or fly larvae for cleaning non-healing wounds. "MDT has been around for centuries -- so it's certainly not new, but there has been a resurgence of interest," said dermatologist and wound-care specialist Elliot N. Mostow, M.D., of Wound Care Associates of Akron (Ohio).
New topicals attack AK from myriad angles
March 1st 2004Waikoloa, Hawaii - Topical treatments for actinic keratosis can attack the problem internally and externally because of varying mechanisms of action, said James Del Rosso, D.O., as he reviewed advances in AK therapies Hawaii Dermatology Seminar.
Clinical variants dictate KS treatment
March 1st 2004Washington, D.C. - There are several clinical variants of Kaposi's sarcoma (KS), and appropriate treatment and response to treatment differ according to the clinical variant, according to Katie Pang, M.D., a clinical research fellow working with Dr. Stephen Tyring at the Center for Clinical Studies in Houston, Texas. The four major clinical variants are classic KS, KS in iatrogenically immunosuppressed patients, AIDS-related epidemic KS, and African endemic KS. HHV-8 is the etiological agent of all of the clinical types of KS.
New anti-dandruff foam looks promising
March 1st 2004Washington - A novel thermophobic foam containing three active ingredients to fight dandruff is at least as effective as standard anti-dandruff treatment, and offers the advantages of a non-greasy formulation that is fast-acting and not irritating to the hair or scalp, according to Massimo Milani, M.D., the medical director and head of technology and development at Mipharm SpA in Milan, Italy.
Less is more in rosacea patients' routine
March 1st 2004Waikoloa, Hawaii- When counseling rosacea patients on routine skincare products, the dermatologist's main mission is to keep the skincare simple and thus avoid the irritation that triggers an exacerbation of rosacea, according to Zoe D. Draelos, M.D.